ArticleScientific reports2019

Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.

Laura L Stafman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.